Abstract CT191: Interim results from CLASSICAL-Lung, phase 1b/2 study of pepinemab (VX15/2503) in combination with avelumab in advanced NSCLC

Document Type

Abstract

Publication Date

8-2020

Publication Title

Cancer Research

Clinical Institute

Cancer

Department

Oncology

Department

Earle A. Chiles Research Institute


Share

COinS